Overview
Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers
Status:
Completed
Completed
Trial end date:
2009-09-01
2009-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Evaluation of efficacy and safety of SBG vs placebo in the treatment of chronic diabetic foot ulcers.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Biotec Pharmacon ASA
Criteria
Inclusion Criteria:- Patients with chronic diabetic foot ulcer
Exclusion Criteria:
- Insufficient nutritional status, renal function or diabetes control